{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Sars-CoV2&page=51", "query": { "condition": "Sars-CoV2", "page": 51 }, "page_size": 10 }, "pagination": { "page": 51, "page_size": 10, "total_count": 1235, "total_pages": 124, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Sars-CoV2&page=52&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Sars-CoV2&page=50&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-28T10:19:40.475Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04734873", "title": "CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Covid-19" ], "interventions": [ { "name": "CPI-006 2 mg/kg + SOC", "type": "DRUG" }, { "name": "CPI-006 1 mg/kg + SOC", "type": "DRUG" }, { "name": "Placebo + SOC", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Corvus Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 46, "start_date": "2021-02-25", "completion_date": "2021-08-18", "has_results": true, "last_update_posted_date": "2022-09-21", "last_synced_at": "2026-10-28T10:19:40.475Z", "location_count": 13, "location_summary": "Chula Vista, California • El Centro, California • La Mesa, California + 10 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "El Centro", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04734873" }, { "nct_id": "NCT06404073", "title": "RECOVER-ENERGIZE Platform Protocol_Appendix B (Structured Pacing (PEM))", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Long COVID", "Long Covid19", "Long Covid-19" ], "interventions": [ { "name": "Structured Pacing", "type": "BEHAVIORAL" }, { "name": "Usual Care", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2024-07-17", "completion_date": "2025-11-17", "has_results": true, "last_update_posted_date": "2026-10-06", "last_synced_at": "2026-10-28T10:19:40.475Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06404073" }, { "nct_id": "NCT05139979", "title": "Yogic Breathing and Guided Meditation for Long Covid Symptoms", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "COVID-19", "Stress", "Shortness of Breath" ], "interventions": [ { "name": "Breathing and Wellness Webinar", "type": "BEHAVIORAL" }, { "name": "Routine Daily Activity", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Beth Israel Deaconess Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 189, "start_date": "2021-09-15", "completion_date": "2024-02-07", "has_results": false, "last_update_posted_date": "2025-02-06", "last_synced_at": "2026-10-28T10:19:40.475Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05139979" }, { "nct_id": "NCT04368988", "title": "Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "SARS-CoV-2 rS - Phase 1", "type": "BIOLOGICAL" }, { "name": "SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 1", "type": "BIOLOGICAL" }, { "name": "Normal saline solution (NSS), Placebo - Phase 1", "type": "OTHER" }, { "name": "Normal saline solution (NSS), Placebo - Phase 2", "type": "OTHER" }, { "name": "SARS-CoV-2 rS/Matrix-M Adjuvant, Day 0 - Phase 1", "type": "BIOLOGICAL" }, { "name": "Normal saline solution (NSS), Placebo, Day 21 - Phase 1", "type": "OTHER" }, { "name": "SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 2", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Novavax", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "84 Years", "sex": "ALL", "summary": "18 Years to 84 Years" }, "enrollment_count": 1419, "start_date": "2020-05-25", "completion_date": "2022-06-01", "has_results": false, "last_update_posted_date": "2023-04-10", "last_synced_at": "2026-10-28T10:19:40.475Z", "location_count": 8, "location_summary": "Savannah, Georgia • Meridian, Idaho • Newton, Kansas + 5 more", "locations": [ { "city": "Savannah", "state": "Georgia" }, { "city": "Meridian", "state": "Idaho" }, { "city": "Newton", "state": "Kansas" }, { "city": "Wichita", "state": "Kansas" }, { "city": "Lexington", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT04368988" }, { "nct_id": "NCT07655180", "title": "Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "COVID-19 mRNA vaccine", "type": "DRUG" }, { "name": "VYD2311", "type": "DRUG" }, { "name": "Placebo (Normal Saline)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Invivyd, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 210, "start_date": "2026-06-08", "completion_date": "2026-08-15", "has_results": false, "last_update_posted_date": "2026-10-14", "last_synced_at": "2026-10-28T10:19:40.475Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07655180" }, { "nct_id": "NCT04402814", "title": "IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing.", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "SARS-CoV 2" ], "interventions": [ { "name": "Clungene rapid test cassette", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Fadi Haddad, M.D.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 90, "start_date": "2020-05-05", "completion_date": "2020-12-01", "has_results": false, "last_update_posted_date": "2020-07-27", "last_synced_at": "2026-10-28T10:19:40.475Z", "location_count": 3, "location_summary": "La Mesa, California • San Diego, California", "locations": [ { "city": "La Mesa", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04402814" }, { "nct_id": "NCT05771714", "title": "Clinical Performance Evaluation of the CareSuperb™ COVID-19 Antigen Home Test", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "CareSuperb COVID-19 Antigen Home Test Kit", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "AccessBio, Inc.", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 786, "start_date": "2023-01-09", "completion_date": "2023-05-11", "has_results": false, "last_update_posted_date": "2023-07-13", "last_synced_at": "2026-10-28T10:19:40.475Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05771714" }, { "nct_id": "NCT05142306", "title": "A COVID-19 Study to Evaluate Safety and PK of COVID-HIG Administered Through IM, SC, or IV Routes to SARS-CoV-2 Uninfected Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "SARS-CoV-2 Infection" ], "interventions": [ { "name": "COVID-HIG", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Emergent BioSolutions", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "59 Years", "sex": "ALL", "summary": "18 Years to 59 Years" }, "enrollment_count": 23, "start_date": "2021-12-07", "completion_date": "2022-05-31", "has_results": true, "last_update_posted_date": "2025-06-08", "last_synced_at": "2026-10-28T10:19:40.475Z", "location_count": 2, "location_summary": "Miami, Florida • Springfield, Missouri", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Springfield", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT05142306" }, { "nct_id": "NCT04536935", "title": "Mobile Mental Health Apps for Suicide Prevention", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Depression", "Anxiety", "Emotional Regulation" ], "interventions": [ { "name": "Mobile Mental Health App - 1", "type": "BEHAVIORAL" }, { "name": "Mobile Mental Health App - 2", "type": "BEHAVIORAL" }, { "name": "Mobile Mental Health App - 3", "type": "BEHAVIORAL" }, { "name": "Mobile Mental Health App - 4", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 838, "start_date": "2020-11-30", "completion_date": "2021-06-20", "has_results": true, "last_update_posted_date": "2022-10-20", "last_synced_at": "2026-10-28T10:19:40.475Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT04536935" }, { "nct_id": "NCT04399889", "title": "hCT-MSCs for COVID19 ARDS", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "COVID", "Corona Virus Infection", "COVID19" ], "interventions": [ { "name": "Human cord tissue mesenchymal stromal cells (hCT-MSC) manufactured by Duke University.", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Joanne Kurtzberg, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2020-06-18", "completion_date": "2022-02-16", "has_results": true, "last_update_posted_date": "2022-12-20", "last_synced_at": "2026-10-28T10:19:40.475Z", "location_count": 5, "location_summary": "Boca Raton, Florida • Miami, Florida • Valhalla, New York + 1 more", "locations": [ { "city": "Boca Raton", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Valhalla", "state": "New York" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04399889" } ] }